1. Puri V, Nagpal M, Singh I, Singh M, Dhingra GA, Huanbutta K, et al. A comprehensive review on nutraceuticals: therapy support and formulation challenges. Nutrients. 2022;14:4637.

   Article 
   CAS 
   PubMed 
   PubMed Central 

   Google Scholar 

2. Chopra AS, Lordan R, Horbańczuk OK, Atanasov AG, Chopra I, Horbańczuk JO, et al. The current use and evolving landscape of nutraceuticals. Pharmacol Res. 2022;175:106001.

   Article 
   PubMed 

   Google Scholar 

3. McOmber MA, Shulman RJ. Pediatric functional gastrointestinal disorders. Nutr Clin Pract. 2008;23:268.

   Article 
   PubMed 
   PubMed Central 

   Google Scholar 

4. Fikree A, Byrne P. Management of functional gastrointestinal disorders. Clin Med (Lond). 2021;21:44–52.

   Article 
   PubMed 

   Google Scholar 

5. Nicoletti M. Nutraceuticals and botanicals: overview and perspectives. Int J Food Sci Nutr. 2012;63:2–6.

   Article 
   PubMed 

   Google Scholar 

6. Sut S, Baldan V, Faggian M, Peron G, Dall Acqua S. Nutraceuticals, a new challenge for medicinal chemistry. Curr Med Chem. 2016;23:3198–223.

   Article 
   CAS 
   PubMed 

   Google Scholar 

7. Sachdeva V, Roy A, Bharadvaja N. Current prospects of nutraceuticals: a review. Curr Pharm Biotechnol. 2020;21:884–96.

   Article 
   CAS 
   PubMed 

   Google Scholar 

8. Semba RD. The discovery of the vitamins. Int J Vitam Nutr Res. 2012;82:310–5.

   Article 
   CAS 
   PubMed 

   Google Scholar 

9. Darnton-Hill I. Public health aspects in the prevention and control of vitamin deficiencies. Curr Dev Nutr. 2019;3:nzz075.

   Article 
   PubMed 
   PubMed Central 

   Google Scholar 

10. Ronis MJJ, Pedersen KB, Watt J. Adverse effects of nutraceuticals and dietary supplements. Annu Rev Pharmacol Toxicol. 2018;58:583–601.

    Article 
    CAS 
    PubMed 

    Google Scholar 

11. Vettorazzi A, López de Cerain A, Sanz-Serrano J, Gil AG, Azqueta A. European regulatory framework and safety assessment of food-related bioactive compounds. Nutrients. 2020;12:E613.

    Article 

    Google Scholar 

12. Gul K, Singh AK, Jabeen R. Nutraceuticals and functional foods: the foods for the future world. Crit Rev Food Sci Nutr. 2016;56:2617–27.

    Article 
    CAS 
    PubMed 

    Google Scholar 

13. McClements DJ, Li F, Xiao H. The nutraceutical bioavailability classification scheme: classifying nutraceuticals according to factors limiting their oral bioavailability. Annu Rev Food Sci Technol. 2015;6:299–327.

    Article 
    CAS 
    PubMed 

    Google Scholar 

14. Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491–502.

    Article 
    PubMed 

    Google Scholar 

15. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–14.

    Article 
    PubMed 

    Google Scholar 

16. Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17:687–701.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

17. Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18:649–67.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

18. Santini A, Cammarata SM, Capone G, Ianaro A, Tenore GC, Pani L, et al. Nutraceuticals: opening the debate for a regulatory framework. Br J Clin Pharmcol. 2018;84:659–72.

    Article 

    Google Scholar 

19. Guarino A, Guandalini S, Lo Vecchio A. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2015;49:S37–45.

    Article 
    CAS 
    PubMed 

    Google Scholar 

20. Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Orel R, et al. Use of probiotics for the management of acute gastroenteritis in children: an update. J Pediatr Gastroenterol Nutr. 2020;71:261–9.

    Article 
    PubMed 

    Google Scholar 

21. Szajewska H, Berni Canani R, Domellöf M, Guarino A, Hojsak I, Indrio F, et al. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications. J Pediatr Gastroenterol Nutr. 2023;76:232–47.

    Article 
    PubMed 

    Google Scholar 

22. Szajewska H, Kołodziej M, Zalewski BM. Systematic review with meta-analysis: saccharomyces boulardii for treating acute gastroenteritis in children—a 2020 update. Alimentary Pharmacol Therapeutics. 2020;51:678–88.

    Article 

    Google Scholar 

23. Szajewska H, Kołodziej M, Gieruszczak-Białek D, Skórka A, Ruszczyński M, Shamir R. Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children – a 2019 update. Aliment Pharmacol Ther. 2019;49:1376–84.

    Article 
    PubMed 

    Google Scholar 

24. Patro-Gołąb B, Szajewska H. Systematic review with meta-analysis: lactobacillus reuteri DSM 17938 for treating acute gastroenteritis in children. an update. Nutrients. 2019;11:2762.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

25. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Møller PL, Pedersen P, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J. 2002;21:411–6.

    Article 
    PubMed 

    Google Scholar 

26. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Møller PL, Tvede M, et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J. 2002;21:417–9.

    Article 
    PubMed 

    Google Scholar 

27. Martinelli M, Banderali G, Bobbio M, Civardi E, Chiara A, D’Elios S, et al. Probiotics’ efficacy in paediatric diseases: which is the evidence? A critical review on behalf of the Italian society of pediatrics. Ital J Pediatr. 2020;46:104.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

28. Guarino A, Lo Vecchio A, Dias JA, Berkley JA, Boey C, Bruzzese D, et al. Universal recommendations for the management of acute diarrhea in nonmalnourished children. J Pediatr Gastroenterol Nutr. 2018;67:586–93.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

29. Hojsak I, Kolaček S, Mihatsch W, Mosca A, Shamir R, Szajewska H, et al. Synbiotics in the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications. J Pediatr Gastroenterol Nutr. 2023;76:102–8.

    Article 
    PubMed 

    Google Scholar 

30. Vandenplas Y, De Hert SG, PROBIOTICAL-study group. Randomised clinical trial: the synbiotic food supplement Probiotical vs. placebo for acute gastroenteritis in children. Aliment Pharm Ther. 2011;34:862–7.

    Article 
    CAS 

    Google Scholar 

31. Kluijfhout S, Trieu T-V, Vandenplas Y. Efficacy of the probiotic probiotical confirmed in acute gastroenteritis. Pediatr Gastroenterol Hepatol Nutr. 2020;23:464–71.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

32. Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ. 2002;324:1345–6.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

33. Szajewska H, Canani RB, Guarino A, Hojsak I, Indrio F, Kolacek S, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr. 2016;62:495–506.

    Article 
    CAS 
    PubMed 

    Google Scholar 

34. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic‐associated diarrhea. Cochrane Database Syst Rev. 2019;2019:CD004827.

    PubMed Central 

    Google Scholar 

35. Zhang Y-Z, Li Y-Y. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20:91–99.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

36. Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne). 2021;8:765474.

    Article 
    PubMed 

    Google Scholar 

37. Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014;7:113–20.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

38. Ban Q-Y, Liu M, Ding N, Chen Y, Lin Q, Zha J-M, et al. Nutraceuticals for the Treatment of IBD: current progress and future directions. Front Nutr. 2022;9:794169.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

39. Scarallo L, Lionetti P. Dietary management in pediatric patients with crohn’s disease. Nutrients. 2021;13:1611.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

40. Green N, Miller T, Suskind D, Lee D. A review of dietary therapy for IBD and a vision for the future. Nutrients. 2019;11:947.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

41. Nousiainen P, Merras-Salmio L, Aalto K, Kolho K-L. Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis. BMC Complement Alter Med. 2014;14:124.

    Article 

    Google Scholar 

42. Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013;19:650–61.

    Article 
    PubMed 

    Google Scholar 

43. IBD in EPIC Study Investigators, Tjonneland A, Overvad K, Bergmann MM, Nagel G, Linseisen J, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut. 2009;58:1606–11.

    Article 

    Google Scholar 

44. Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids-the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan. Prog Lipid Res. 1996;35:409–57.

    Article 
    CAS 
    PubMed 

    Google Scholar 

45. Balić A, Vlašić D, Žužul K, Marinović B, Bukvić Mokos Z. Omega-3 versus Omega-6 Polyunsaturated fatty acids in the prevention and treatment of inflammatory skin diseases. Int J Mol Sci. 2020;21:741.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

46. Bischoff SC, Bager P, Escher J, Forbes A, Hébuterne X, Hvas CL, et al. ESPEN guideline on clinical nutrition in inflammatory bowel disease. Clin Nutr. 2023;42:352–79.

    Article 
    PubMed 

    Google Scholar 

47. Bhullar KS, Jha A, Youssef D, Rupasinghe HPV. Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties. Molecules. 2013;18:5389–404.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

48. Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced dose titration study. J Pediatr Gastroenterol Nutr. 2013;56:277–9.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

49. Lin Y, Liu H, Bu L, Chen C, Ye X. Review of the effects and mechanism of curcumin in the treatment of inflammatory bowel disease. Front Pharm. 2022;13:908077.

    Article 
    CAS 

    Google Scholar 

50. Mouzaoui S, Rahim I, Djerdjouri B. Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice. Int Immunopharmacol. 2012;12:302–11.

    Article 
    CAS 
    PubMed 

    Google Scholar 

51. Topcu-Tarladacalisir Y, Akpolat M, Uz YH, Kizilay G, Sapmaz-Metin M, Cerkezkayabekir A, et al. Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid-induced colitis: the roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J Med Food. 2013;16:296–305.

    Article 
    CAS 
    PubMed 

    Google Scholar 

52. Yue W, Liu Y, Li X, Lv L, Huang J, Liu J. Curcumin ameliorates dextran sulfate sodium-induced colitis in mice via regulation of autophagy and intestinal immunity. Turk J Gastroenterol. 2019;30:290–8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

53. Li C-P, Li J-H, He S-Y, Chen O, Shi L. Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis. Genet Mol Res. 2015;14:3450–8.

    Article 
    CAS 
    PubMed 

    Google Scholar 

54. Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, et al. Management of paediatric ulcerative colitis, Part 1: ambulatory care-an evidence-based guideline from European Crohn’s and Colitis Organization and European Society of paediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2018;67:257–91.

    Article 
    PubMed 

    Google Scholar 

55. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8:92.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

56. Hardy H, Harris J, Lyon E, Beal J, Foey AD. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients. 2013;5:1869–912.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

57. Valcheva R, Koleva P, Martínez I, Walter J, Gänzle MG, Dieleman LA. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels. Gut Microbes. 2018;10:334–57.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

58. Damaskos D, Kolios G. Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’. Br J Clin Pharmacol. 2008;65:453–67.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

59. Guo J, Zhang M, Wang H, Li N, Lu Z, Li L, et al. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice. J Food Biochem. 2022;46:e14063.

    Article 
    CAS 
    PubMed 

    Google Scholar 

60. Ilyés T, Silaghi CN, Crăciun AM. Diet-related changes of short-chain fatty acids in blood and feces in obesity and metabolic syndrome. Biology. 2022;11:1556.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

61. Choi S-H, Lee S-H, Kim MG, Lee HJ, Kim G-B. Lactobacillus plantarum CAU1055 ameliorates inflammation in lipopolysaccharide-induced RAW264.7 cells and a dextran sulfate sodium–induced colitis animal model. J Dairy Sci. 2019;102:6718–25.

    Article 
    CAS 
    PubMed 

    Google Scholar 

62. Michielan A, D’Incà R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediat Inflamm. 2015;2015:628157.

    Article 

    Google Scholar 

63. Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, et al. Alteration of gut microbiota in Inflammatory Bowel Disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens. 2019;8:126.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

64. Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009;104:437–43.

    Article 
    CAS 
    PubMed 

    Google Scholar 

65. Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther. 2012;35:327–34.

    Article 
    CAS 
    PubMed 

    Google Scholar 

66. Henker J, Müller S, Laass MW, Schreiner A, Schulze J. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol. 2008;46:874–5.

    Article 
    CAS 
    PubMed 

    Google Scholar 

67. Miele E, Shamir R, Aloi M, Assa A, Braegger C, Bronsky J, et al. Nutrition in pediatric inflammatory bowel disease: a position paper on behalf of the porto inflammatory bowel disease group of the European Society of pediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2018;66:687–708.

    Article 
    PubMed 

    Google Scholar 

68. Merga Y, Campbell BJ, Rhodes JM. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy. Dig Dis. 2014;32:475–83.

    Article 
    PubMed 

    Google Scholar 

69. Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69:2232–43.

    Article 
    CAS 
    PubMed 

    Google Scholar 

70. Belkaid Y, Hand T. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–41.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

71. Wu H-J, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3:4–14.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

72. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, et al. An update on the use and investigation of probiotics in health and disease. Gut. 2013;62:787–96.

    Article 
    CAS 
    PubMed 

    Google Scholar 

73. Iheozor-Ejiofor Z, Kaur L, Gordon M, Baines PA, Sinopoulou V, Akobeng AK. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020;2020:CD007443.

    PubMed Central 

    Google Scholar 

74. Rufino MN, da Costa AL, Jorge EN, Paiano VF, Camparoto ML, Keller R, et al. Synbiotics improve clinical indicators of ulcerative colitis: systematic review with meta-analysis. Nutr Rev. 2022;80:157–64.

    Article 
    PubMed 

    Google Scholar 

75. Hansen R, Mahdi G, McIntyre K, Macfarlane GT, Macfarlane S, Wilson DC. Synbiotics for inflammatory bowel disease: useful in adults but problematic in paediatrics. Arch Dis Child. 2011;96:A18–A19.

    Article 

    Google Scholar 

76. Légeret C, Stienen Y, Furlano R, Köhler H. Effectivity of treatment for children with functional dyspepsia. Sci Rep. 2022;12:1467.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

77. Goyal O, Nohria S, Batta S, Dhaliwal A, Goyal P, Sood A. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial. J Gastroenterol Hepatol. 2022;37:301–9.

    Article 
    CAS 
    PubMed 

    Google Scholar 

78. Duncanson K, Burns G, Pryor J, Keely S, Talley NJ. Mechanisms of food-induced symptom induction and dietary management in functional dyspepsia. Nutrients. 2021;13:1109.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

79. Cenni S, Sesenna V, Boiardi G, Casertano M, Di Nardo G, Esposito S, et al. The mediterranean diet in paediatric gastrointestinal disorders. Nutrients. 2023;15:79.

    Article 
    CAS 

    Google Scholar 

80. Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2022;71:1117–26.

    Article 
    CAS 
    PubMed 

    Google Scholar 

81. Tan VP. The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia. J Gastroenterol Hepatol. 2017;32:46–52.

    Article 
    PubMed 

    Google Scholar 

82. Thomassen RA, Luque V, Assa A, Borrelli O, Broekaert I, Dolinsek J, et al. An ESPGHAN position paper on the use of Low-FODMAP diet in pediatric gastroenterology. J Pediatr Gastroenterol Nutr. 2022;75:356–68.

    Article 
    CAS 
    PubMed 

    Google Scholar 

83. Shahrajabian MH, Sun W, Cheng Q. Clinical aspects and health benefits of ginger (Zingiber officinale) in both traditional Chinese medicine and modern industry. Acta Agric Scand Sect B — Soil Plant Sci. 2019;69:546–56.

    CAS 

    Google Scholar 

84. Mao Q-Q, Xu X-Y, Cao S-Y, Gan R-Y, Corke H, Beta T, et al. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods. 2019;8:185.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

85. Marx W, Kiss N, Isenring L. Is ginger beneficial for nausea and vomiting? An update of the literature. Curr Opin Support Palliat Care. 2015;9:189–95.

    Article 
    PubMed 

    Google Scholar 

86. Hu M-L, Rayner CK, Wu K-L, Chuah S-K, Tai W-C, Chou Y-P, et al. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011;17:105–10.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

87. Buchwald-Werner S, Fujii H, Reule C, Schoen C. Perilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study. BMC Complement Alter Med. 2014;14:173.

    Article 

    Google Scholar 

88. Koppen IJN, Vriesman MH, Saps M, Rajindrajith S, Shi X, van Etten-Jamaludin FS, et al. Prevalence of functional defecation disorders in children: a systematic review and meta-analysis. J Pediatr. 2018;198:121–30.e6.

    Article 
    PubMed 

    Google Scholar 

89. Koppen IJN, Nurko S, Saps M, Di Lorenzo C, Benninga MA. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol. 2017;11:193–201.

    CAS 
    PubMed 

    Google Scholar 

90. van den Berg MM, Benninga MA, Di, Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006;101:2401–9.

    Article 
    PubMed 

    Google Scholar 

91. Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58:258–74.

    Article 
    CAS 
    PubMed 

    Google Scholar 

92. Murakami K, Sasaki S, Okubo H, Takahashi Y, Hosoi Y, Itabashi M, et al. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr. 2007;61:616–22.

    Article 
    CAS 
    PubMed 

    Google Scholar 

93. Asakura K, Masayasu S, Sasaki S. Dietary intake, physical activity, and time management are associated with constipation in preschool children in Japan. Asia Pac J Clin Nutr. 2017;26:118–29.

    PubMed 

    Google Scholar 

94. Karagiozoglou-Lampoudi T, Daskalou E, Agakidis C, Savvidou A, Apostolou A, Vlahavas G. Personalized diet management can optimize compliance to a high-fiber, high-water diet in children with refractory functional constipation. J Acad Nutr Diet. 2012;112:725–9.

    Article 
    PubMed 

    Google Scholar 

95. Santucci NR, Chogle A, Leiby A, Mascarenhas M, Borlack RE, Lee A, et al. Non-pharmacologic approach to pediatric constipation. Complement Ther Med. 2021;59:102711.

    Article 
    PubMed 

    Google Scholar 

96. Koppen IJN, Benninga MA, Tabbers MM. Is there a role for Pre-, Pro- and synbiotics in the treatment of functional constipation in children? A systematic review. J Pediatr Gastroenterol Nutr. 2016;63:S27–35.

    PubMed 

    Google Scholar 

97. Closa-Monasterolo R, Ferré N, Castillejo-DeVillasante G, Luque V, Gispert-Llaurado M, Zaragoza-Jordana M, et al. The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study. Int J Food Sci Nutr. 2017;68:587–94.

    Article 
    CAS 
    PubMed 

    Google Scholar 

98. Lohner S, Jakobik V, Mihályi K, Soldi S, Vasileiadis S, Theis S, et al. Inulin-Type Fructan Supplementation of 3- to 6-Year-Old Children Is Associated with Higher Fecal Bifidobacterium Concentrations and Fewer Febrile Episodes Requiring Medical Attention. J Nutr. 2018;148:1300–8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

99. Shahramian I, Kalvandi G, Javaherizadeh H, Khalili M, Noori NM, Delaramnasab M, et al. The effects of prebiotic supplementation on weight gain, diarrhoea, constipation, fever and respiratory tract infections in the first year of life. J Paediatr Child Health. 2018;54:875–80.

    Article 
    PubMed 

    Google Scholar 

100. Han Y, Zhang L, Liu X-Q, Zhao Z-J, Lv L-X. Effect of glucomannan on functional constipation in children: a systematic review and meta-analysis of randomised controlled trials. Asia Pac J Clin Nutr. 2017;26:471–7.

     PubMed 

     Google Scholar 

101. Staiano A, Simeone D, Del Giudice E, Miele E, Tozzi A, Toraldo C. Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children. J Pediatr. 2000;136:41–5.

     Article 
     CAS 
     PubMed 

     Google Scholar 

102. Rojo-Poveda O, Barbosa-Pereira L, Zeppa G, Stévigny C. Cocoa bean shell—a by-product with nutritional properties and biofunctional potential. Nutrients. 2020;12:1123.

     Article 
     CAS 
     PubMed 
     PubMed Central 

     Google Scholar 

103. Castillejo G, Bulló M, Anguera A, Escribano J, Salas-Salvadó J. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients. Pediatrics. 2006;118:e641–648.

     Article 
     PubMed 

     Google Scholar 

104. Kokke FTM, Scholtens PAMJ, Alles MS, Decates TS, Fiselier TJW, Tolboom JJM, et al. A dietary fiber mixture versus lactulose in the treatment of childhood constipation: a double-blind randomized controlled trial. J Pediatr Gastroenterol Nutr. 2008;47:592–7.

     Article 
     CAS 
     PubMed 

     Google Scholar 

105. Quitadamo P, Coccorullo P, Giannetti E, Romano C, Chiaro A, Campanozzi A, et al. A randomized, prospective, comparison study of a mixture of acacia fiber, psyllium fiber, and fructose vs polyethylene glycol 3350 with electrolytes for the treatment of chronic functional constipation in childhood. J Pediatr. 2012;161:710–15.e1.

     Article 
     CAS 
     PubMed 

     Google Scholar 

106. Weber TK, Toporovski MS, Tahan S, Neufeld CB, de Morais MB. Dietary fiber mixture in pediatric patients with controlled chronic constipation. J Pediatr Gastroenterol Nutr. 2014;58:297–302.

     Article 
     CAS 
     PubMed 

     Google Scholar 

107. Bu L-N, Chang M-H, Ni Y-H, Chen H-L, Cheng C-C. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int. 2007;49:485–90.

     Article 
     PubMed 

     Google Scholar 

108. Wojtyniak K, Horvath A, Dziechciarz P, Szajewska H. Lactobacillus casei rhamnosus Lcr35 in the management of functional constipation in children: a randomized trial. J Pediatr. 2017;184:101–105.e1.

     Article 
     PubMed 

     Google Scholar 

109. Jadrešin O, Sila S, Trivić I, Mišak Z, Hojsak I, Kolaček S. Lack of benefit of lactobacillus reuteri DSM 17938 as an addition to the treatment of functional constipation. J Pediatr Gastroenterol Nutr. 2018;67:763–6.

     Article 
     PubMed 

     Google Scholar 

110. Wegner A, Banaszkiewicz A, Kierkus J, Landowski P, Korlatowicz-Bilar A, Wiecek S. et al. The effectiveness of lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.Clin Res Hepatol Gastroenterol. 2018;42:494–500.

     Article 
     CAS 
     PubMed 

     Google Scholar 

111. Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. J Pediatr. 2010;157:598–602.

     Article 
     PubMed 

     Google Scholar 

112. Khodadad A, Sabbaghian M. Role of synbiotics in the treatment of childhood constipation: a double-blind randomized placebo controlled trial. Iran J Pediatr. 2010;20:387–92.

     PubMed 
     PubMed Central 

     Google Scholar 

113. Baştürk A, Artan R, Atalay A, Yılmaz A. Investigation of the efficacy of synbiotics in the treatment of functional constipation in children: a randomized double-blind placebo-controlled study. Turk J Gastroenterol. 2017;28:388–93.

     Article 
     PubMed 

     Google Scholar 

114. García Contreras AA, Vásquez Garibay EM, Sánchez Ramírez CA, Fafutis Morris M, Delgado Rizo V. Lactobacillus reuteri DSM 17938 and Agave Inulin in children with cerebral palsy and chronic constipation: a double-blind randomized placebo controlled clinical trial. Nutrients. 2020;12:2971.

     Article 
     PubMed 

     Google Scholar 

115. Eghbali A, Ghaffari K, Khalilpour A, Afzal RR, Eghbali A, Ghasemi A. The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: a double-blind randomized clinical trial. Pediatr Blood Cancer. 2023;70:e30328.

     Article 
     PubMed 

     Google Scholar 

116. Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20:6759–73.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

117. Bonetto S, Boano V, Valenzi E, Saracco GM, Pellicano R. Non-pharmacological strategies to treat irritable bowel syndrome: 2022 update. Minerva Gastroenterol (Torino). 2022;68:475–81.

     PubMed 

     Google Scholar 

118. Giannetti E, de’Angelis G, Turco R, Campanozzi A, Pensabene L, Salvatore S, et al. Subtypes of irritable bowel syndrome in children: prevalence at diagnosis and at follow-up. J Pediatr. 2014;164:1099–1103.e1.

     Article 
     PubMed 

     Google Scholar 

119. Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: current knowledge, challenges and opportunities. World J Gastroenterol. 2018;24:2211–35.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

120. Corsello A, Pugliese D, Gasbarrini A, Armuzzi A. Diet and nutrients in gastrointestinal chronic diseases. Nutrients. 2020;12:2693

     Article 
     CAS 
     PubMed 
     PubMed Central 

     Google Scholar 

121. Cozma-Petruţ A, Loghin F, Miere D, Dumitraşcu DL. Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients! World J Gastroenterol. 2017;23:3771–83.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

122. Tuck CJ, Muir JG, Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2014;8:819–34.

     Article 
     CAS 
     PubMed 

     Google Scholar 

123. Algera J, Colomier E, Simrén M. The dietary management of patients with irritable bowel syndrome: a narrative review of the existing and emerging evidence. Nutrients. 2019;11:2162.

     Article 
     CAS 
     PubMed 
     PubMed Central 

     Google Scholar 

124. Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. 2016;55:897–906.

     Article 
     CAS 
     PubMed 

     Google Scholar 

125. Benninga M, Candy DCA, Catto-Smith AG, Clayden G, Loening-Baucke V, Lorenzo CD, et al. The Paris Consensus on Childhood Constipation Terminology (PACCT) Group. J Pediatr Gastroenterol Nutr. 2005;40:273.

     Article 
     PubMed 

     Google Scholar 

126. Dossett ML, Cohen EM, Cohen J. Integrative medicine for gastrointestinal disease. Prim Care. 2017;44:265–80.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

127. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:718–27.

     Article 
     CAS 
     PubMed 

     Google Scholar 

128. Dale HF, Rasmussen SH, Asiller ÖÖ, Lied GA. Probiotics in irritable bowel syndrome: an up-to-date systematic review. Nutrients. 2019;11:2048.

     Article 
     CAS 
     PubMed 
     PubMed Central 

     Google Scholar 

129. Hayes PA, Fraher MH, Quigley EMM. Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N. Y). 2014;10:164–74.

     PubMed 

     Google Scholar 

130. Moayyedi P, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1367–74.

     Article 
     CAS 
     PubMed 

     Google Scholar 

131. Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, et al. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Paediatr Drugs. 2015;17:199–216.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

132. Portincasa P, Bonfrate L, Scribano MLL, Kohn A, Caporaso N, Festi D, et al. Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. J Gastrointest Liver Dis. 2016;25:151–7.

     Article 

     Google Scholar 

133. Ng QX, Soh AYS, Loke W, Venkatanarayanan N, Lim DY, Yeo W-S. A Meta-analysis of the clinical use of curcumin for Irritable Bowel Syndrome (IBS). J Clin Med. 2018;7:298.

     Article 
     CAS 
     PubMed 
     PubMed Central 

     Google Scholar 

134. Fiore G, Pascuzzi MC, Di Profio E, Corsello A, Agostinelli M, La Mendola A, et al. Bioactive compounds in childhood obesity and associated metabolic complications: current evidence, controversies and perspectives. Pharmacol Res. 2023;187:106599.

     Article 
     CAS 
     PubMed 

     Google Scholar 

135. Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N. Engl J Med. 2006;354:1698–705.

     Article 
     CAS 
     PubMed 

     Google Scholar 

136. Bonvanie IJ, Weghorst AA, Holtman GA, Russchen HA, Fickweiler F, Verkade HJ, et al. Oral ondansetron for paediatric gastroenteritis in primary care: a randomised controlled trial. Br J Gen Pract. 2021;71:e728–e735.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

137. Nocerino R, Cecere G, Micillo M, De Marco G, Ferri P, Russo M, et al. Efficacy of ginger as antiemetic in children with acute gastroenteritis: a randomised controlled trial. Aliment Pharm Ther. 2021;54:24–31.

     Article 
     CAS 

     Google Scholar 

138. Kim S-D, Kwag E-B, Yang M-X, Yoo H-S. Efficacy and safety of ginger on the side effects of chemotherapy in breast cancer patients: systematic review and meta-analysis. Int J Mol Sci. 2022;23:11267.

     Article 
     CAS 
     PubMed 
     PubMed Central 

     Google Scholar 

139. Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer. 2011;56:234–8.

     Article 
     PubMed 

     Google Scholar 

140. Zhu W, Dai Y, Huang M, Li J. Efficacy of ginger in preventing postoperative nausea and vomiting: a systematic review and meta-analysis. J Nurs Scholarsh. 2021;53:671–9.

     Article 
     PubMed 

     Google Scholar 

141. Beiranvand S, Alvani M, Sorori MM. The effect of ginger on postoperative nausea and vomiting among patients undergoing upper and lower limb surgery: a randomized controlled trial. J Perianesthesia Nurs. 2022;37:365–8.

     Article 

     Google Scholar 

142. Seidi J, Ebnerasooli S, Shahsawari S, Nzarian S. The influence of oral ginger before operation on nausea and vomiting after cataract surgery under general anesthesia: a double-blind placebo-controlled randomized clinical trial. Electron Physician. 2017;9:3508–14.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

143. Krupa-Kozak U, Drabińska N, Jarocka-Cyrta E. The effect of oligofructose-enriched inulin supplementation on gut microbiota, nutritional status and gastrointestinal symptoms in paediatric coeliac disease patients on a gluten-free diet: study protocol for a pilot randomized controlled trial. Nutr J. 2017;16:47.

     Article 
     PubMed 
     PubMed Central 

     Google Scholar 

144. Loening-Baucke V, Miele E, Staiano A. Fiber (glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics. 2004;113:e259–264.

     Article 
     PubMed 

     Google Scholar 

145. Cassettari VMG, Machado NC, Lourenção PLT, de A, Carvalho MA, Ortolan EVP. Combinations of laxatives and green banana biomass on the treatment of functional constipation in children and adolescents: a randomized study. J Pediatr. 2019;95:27–33.

     Article 

     Google Scholar 

146. Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138:125–8.

     Article 
     CAS 
     PubMed 

     Google Scholar 

Download references